Glioblastoma (GBM) continues to show a poor prognosis despite advances in diagnostic and therapeutic approaches. The discovery of reliable prognostic indicators may significantly improve treatment outcome of GBM. In this study, we aimed to explore the function of verbascoside (VB) in GBM and its effects on GBM cell biological processes via let-7g-5p and HMGA2. Differentially expressed GBM-related microRNAs (miRNAs) were initially screened. Different concentrations of VB were applied to U87 and U251 GBM cells, and 50 µmol/L of VB was selected for subsequent experiments. Cells were transfected with let-7g-5p inhibitor or mimic, and overexpression of HMGA2 or siRNA against HMGA2 was induced, followed by treatment with VB. The regulatory relationships between VB, let-7g-5p, HMGA2 and Wnt/β-catenin signalling pathway were determined. The results showed that HMGA2 was a direct target gene of let-7g-5p. VB treatment or let-7g-5p overexpression inhibited HMGA2 expression and the activation of Wnt/β-catenin signalling pathway, which further inhibited cell viability, invasion, migration, tumour growth and promoted GBM cell apoptosis and autophagy. On the contrary, HMGA2 overexpression promoted cell viability, invasion, migration, tumour growth while inhibiting GBM cell apoptosis and autophagy. We demonstrated that VB inhibits cell viability and promotes cell autophagy in GBM cells by up-regulating let-7g-5p and down-regulating HMGA2 via Wnt/β-catenin signalling blockade.
gical resection with adjuvant radiotherapy. 2 Owing to the high usual age of onset, tumour location and poor understanding of GBM pathophysiology, mean survival is approximately only 16 months despite optimal treatment. 3 Regrettably, advances in therapeutic strategies have not translated to increase in the survival rate of patients with GBM. 4 As such, the development of new diagnostic and therapeutic approaches demands improved understanding of the molecular mechanisms that underpin this condition, including both genetic and epigenetic factors. 5 Verbascoside (VB) is a type of herb that has recently received research attention owing to its significant clinical value. 6 Known as an antioxidant, VB has been widely investigated owing to its purported biological and pharmacological capabilities, which include neuroprotective, hepatoprotective, antineoplastic and antiproliferative effects. 7 VB has been shown to alleviate muscle fatigue and reduce oxidative stress brought on by exhaustive exercise through its effect on free radicals and lipid peroxidation. 8 Additionally, VB has exhibited anti-tumour activities. It has been found to significantly decrease tumour cell viability and growth and enhance tumour cell apoptosis in leukaemia. 9 As a member of microRNAs, let-7g-5p is poorly expressed in GBM and suppressed during GBM cell invasion and migration by binding to VSIG4 and blocking the epithelial-mesenchymal pathway. 10 High mobility group A2 (HMGA2), a high mobility group AT-hook (HMGA) protein, has been found to be overexpressed during tumour progression while influencing several gene expression patterns that impact biological processes such as cell survival, differentiation and apoptosis. 11 HMGA2 serves as a competitive endogenous RNA and was found to play a role in lung cancer progression and metastasis, acting via its regulatory network. 12 Reports have also indicated that HMGA2 induces cell invasion and metastasis via the TGFβ signalling pathway, which has been demonstrated in colon and breast cancer. 13 Previous studies have also revealed that several miRNAs could target HMGA2, thus exerting its regulatory functions in many different types of cancers. 14, 15 In GBM, the Wnt/β-catenin signalling pathway is known to act as a vital downstream target. 16 Reports have indicated that Sohlh1 participates in the progression of GBM through its effect on the Wnt/β-catenin signalling pathway. 17 Therefore, our study, in order to identify a novel molecular target for GBM management, framed a hypothesis that VB could repress GBM cell invasion, migration and tumour growth by inhibiting let-7g-5p-mediated HMGA2 via the Wnt/β-catenin signalling pathway. 
| MATERIAL S AND ME THODS

| Ethics statement
| In silico analysis
miRNA expression microarray data of GBM were obtained from the Gene Expression Omnibus (GEO) database (https ://www.ncbi.nlm. nih.gov/geo/). Differences in miRNA expression between normal samples and tumour samples in the microarray data were determined using the GEO2R tool, and the log fold change value of differentially expressed miRNAs was analysed.
| Cell culture
Glioblastoma cell lines A172, SHG139, SHG-44, U87 and U251 were purchased from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, (Shanghai, China). The cells were grown in Dulbecco's Modified Eagle's Medium (DMEM; Sigma) containing 10% foetal bovine serum (FBS), 100 mg/mL streptomycin and penicillin, and incubated with 5% CO 2 in saturated humidity conditions at 37°C. Cells in the logarithmic growth phase were treated with trypsin, followed by centrifugation. After removal of the supernatant, the cells were re-suspended, and 100 µL of suspension (5.0 × 10 4 cells/mL) was seeded into a 96-well plate.
Twenty-four hours after incubation, 0, 1, 20, 40, 60, 80 and 100 µmol/L VB were added into the cell suspension, in individual experiments. A blank group (cells containing DMEM only) and a negative control (NC) group (cells containing NC of the same concentration) were designed for the subsequent experiments. Each experiment was repeated three times.
| Cell counting Kit-8 (CCK-8) assay
A CCK-8 kit (Dojindo) was used to determine cell viability. GBM cell lines (A172, SHG139, SHG-44, U87 and U251) were treated with VB at different concentrations. At approximately 80% confluence, cells were inoculated into a 96-well plate at a plating density of 5000 cells/mL with 100 µL per well. After incubation for 24 hours, 10 μL of CCK (AbMole-M4839, Abmole Bioscience Inc) was added to the cells in each well, followed by incubation for 1-4 hours at 4°C.
Next, 150 μL of dimethyl sulfoxide (DMSO) was added to each well followed by shaking for 10 minutes. An optical density (OD) value at 570 nm was obtained to reflect cell survival using a multimode microplate reader (SpectraMax i3x, Molecular Devices). Cell survival rate was computed as: 100% -(OD value of the experimental group -OD value of the blank group)/(OD value of the NC group -OD value of the blank group) × 100%. IC 50 of VB was calculated in accordance with the inhibition rate of gradient concentration. Th cell lines and drug concentrations presenting the highest IC 50 were selected based on this screening experiment and used in further assays.
| Dual-luciferase reporter gene assay
According to sequences of the binding sites between 3′-untranslated region (UTR) of HMGA2 mRNA and let-7g-5p, target and mutant sequences were synthesized, and Xho I and Not I endonuclease sites were created at the downstream of both sequences.
The cloned product was transferred into a PUC57 carrier, followed by the application of DNA sequencing in order to detect the recombinant plasmid after it had been confirmed as a positive clone.
The plasmid was amplified, and the psiCHECK-2 vector was used (VECT90299, Huayueyang Biotechnology, Co., Ltd.) with cloning sequences inserted to escherichia coli DH5α cells. The plasmids were extracted in accordance with the instructions of the Omega Plasmid Miniprep Kit (D1100-50T, Solarbio Life Science).
Next, 293T/17 cells were seeded in a 6-well plate at a density of 2 × 10 5 cells/well. After cell adherence to the wells, the cells were transfected using the aforementioned methods in a reaction system containing 2 mL of the culture medium, 250 µL of Opti-MEN and 4 µg of plasmids, followed by a 48-h incubation. The effects of let-7g-5p on the luciferase activity of HMGA2 3′-UTR were detected using a dual-luciferase reporter gene assay kit (D0010, Solarbio Life Science) based on the manufacturer's protocol. The fluorescence intensity was assessed using a Glomax20/20 luminometer fluorescence detector (E5311, Zhongmei Biotechnology Co., Ltd., Xi'an).
| RNA pull-down assay
U87 cell lines were transfected with 50 nmol/L biotinylated let-7g-5p wild-type (wt) and 50 nmol/L biotinylated let-7g-5p mutant (mut).
After transfection for 48 hours, the cells were washed with phosphate-buffered saline (PBS) and then cultured with specific lysis buffer (Ambion). Ten minutes later, 50 mL of the lysate was extracted.
The remaining lysate was incubated with M-280 streptavidin-coated magnetic beads (Sigma-Aldrich) containing RNase-free and yeast transfer RNA (tRNA; Sigma-Aldrich). After a 3-hour incubation at 4°C, the mixture was washed twice with cold lysis buffer, thrice with low salt buffer and once with high-salt buffer. Antagonistic let-7g-5p probe was regarded as the NC. Total RNA was extracted using the TRIzol method and the mRNA expression of HMGA2 was measured using reverse transcription quantitative polymerase chain reaction (RT-qPCR).
| Cell transfection and grouping
According to the sequences of HMGA2 obtained from the National Center for Biotechnology Information (NCBI), blank plasmids, HMGA2 vector plasmids and HMGA2 shRNA plasmids were each constructed (Sangon Biotech Shanghai Co., Ltd.). U87 and U251 cells were divided into the following groups: 
| Xenograft tumour in nude mice
The U87 and U251 cells were re-suspended and adjusted to 1 × 10 7 cells/mL with serum-free Roswell royal park memorial institute (RPMI) 1640 medium (Gibco, Invitrogen). A total of 60 specific pathogen free (SPF) male nude mice aged 4 weeks, weighing 14-16 g, (Shanghai SLAC Laboratory Animal Technology Co., Ltd.) were allowed to acclimatize for 1 week and randomly divided into 12 groups (5 nude mice per group). The left axillary part of the nude mice was injected with 1 × 10 6 cells, and they were further injected with VB according to predefined experiment protocols. All nude mice were housed in the same environment and monitored every week. The maximum (a) and minimum diameter (b) of the tumours that appeared were measured using a vernier caliper, and the approximate volume was calculated according to the formula: V = a × b 2 /2. After injection over a 28-day period, the nude mice were killed. The xenograft and metastatic tumours were extracted in order to determine the let-7g-5p expression.
| Scratch test
After transfection for 48 hours, U87 and U251 cells were seeded in a 6-well plate at a density of 1 × 10 5 cells/well. When cells reached approximately 90% confluence, 4 horizontal and perpendicular thin wounds were created respectively using a sterile 200-μL pipette applied with equal force. After discarding the original medium, the cells in each well were incubated with 2 mL of serum-free fresh medium.
The images of the cells were photographed at the 0th and 24th h under an inverted microscope. Five visual fields of each sample were selected randomly to obtain the mean value and relative widths of the scratches were also measured at multiple sites. The rate of wound healing was determined as: (width at the 0th h -width at the 24th h)/width at the 0th h × 100%.
| Transwell assay
After transfection for 48 hours, the U87 and U251 cell lines were starved in serum-free medium for 24 hours, followed by detachment. A cell suspension (3 × 10 4 cells/mL) was prepared using serum-free Opti-MEMI (31985008, Nanjing SenBeiJia Biotechnology Co., Ltd.) containing 10 g/L bovine serum albumin (BSA; 9998S, Shanghai Beinuo Biotechnology Co., Ltd.). Transwell chambers (3422, Beijing Unique Biotechnology Co., Ltd.) were placed into a 24-well plate. The apical chambers were coated with diluted Matrigel (1:8; 40111ES08, Yeasen) and dried at room temperature. After being detached and washed twice with PBS, the cells were re-suspended with RPMI 1640 medium (R7755, Beijing Three replicates were set up in each group.
| Laser confocal microscopy
U87 and U251 cells were seeded onto cover slips in a 48-well culture dish. After a 24-hour treatment process with solutions, the cells were incubated with 5% CO 2 at 37°C and fixed with 4% icecold paraformaldehyde for 15 minutes. After being washed with PBS, the cells were treated with 0.1% Triton-X-100 for 15 minutes and cultured with medium-diluted primary and secondary antibodies at 250 μL/well in an incubator with 5% CO 2 at 37°C. Next, the cells were rinsed with PBS, followed by addition of LC3B polyclonal antibody (1:200; YM3381; ImmunoWay Biotechnology Company), avoiding exposure to light for 20 minutes. The cells were mounted using a drop of anti-fluorescence quenching medium and then observed under a laser confocal microscopy (Keyence) for detection (the excitation wavelength, emission wavelength and intensity distribution for scanning of Cy3 were 543 nm, 560-670 nm, 50; and resolution was 1024:60 n). buffer solutions at the ratio of 1:2: 50. A total of 1 × 10 6 cells were re-suspended with 100 μL of Annexin-V-FITC/PI staining solution. After incubation for 15 minutes at room temperature, 1 mL of HEPES buffer solution (GNM-11344, Shanghai Jingke) was added to the cells, oscillated and mixed evenly. The cells were excited at 488 nm, FITC fluorescence was detected using a 525 nm band-pass filter, whereas PI was detected using a 620 nm band-pass filter to determine cell apoptosis.
| Flow cytometry
| RT-qPCR
Total RNA from U87 and U251 cells was extracted using TRIzol (RP2401, BioTeKe Corporation). RT-qPCR primers of let-7g-5p, LC3, Beclin1, Bax, Bcl-2 and Caspase-3 were designed using the Premier 5.0 software and then synthesized by Invitrogen Corp (Table 1 ). RNA was reversely transcribed into cDNA in accordance with the instructions of the PrimeScript RT kit (RR036A, Takara Biotechnology Co., Ltd.). The primers were amplified using a PCR instrument (7300, Applied Biosystems) in accordance with the instructions of the SYBR ® Premix Ex TaqTM II kit (RR820A, Takara Biotechnology Co., Ltd.). Next, 2 μg of total RNA was used as the template, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was regarded as the internal reference for HMGA2, β-catenin, LC3, Beclin1, Bax, Bcl-2, Caspase-3 and protein kinase C (PKC) and U6 served as internal reference for let-7g-5p. The relative mRNA expression of these genes was determined using the 2 -ΔΔCt method. 18
| Western blot analysis
Total protein of the U87 and U251 cells was extracted using radio-immunoprecipitation assay (RIPA) lysis buffer (R0010, Solarbio Life Science), with protein concentration measured using a bicinchoninic acid (BCA) protein assay kit (G3522-1, GBCBIO Technologies). After polyacrylamide gel electrophoresis (PAGE), the protein was transferred onto nitrocellulose membranes using the wet transfer method and then blocked with 5% BSA for 1 hour at room temperature. The membranes were incubated with the following primary antibodies to LC3 (1:500, ab128025), Beclin1 (1:1000, ab62557), Bax (1:1000, ab53154), Bcl-2 (1:1000, ab59348), Caspase-3 (1:500, ab13847) and PKC (1:1000, ab19031) at 4°C overnight. All antibodies were purchased from Abcam.
Next, the membranes were washed five times with PBS (5 minutes each time) and incubated with horseradish peroxidase (HRP)labelled secondary rabbit anti-human antibody to IgG (1:5000, F020218, Baiaolaibo Science and Technology Ltd.) for 1 hour.
Each membrane was developed using electrochemiluminescence (ECL) (ECL808-25, Biomiga) for 1 minutes. After the solution was discarded, each membrane was covered by preservative film and exposed by X-ray (36209ES01, Shanghai qcbio Science & Technologies, Co., Ltd.) in order to visualize the results. GAPDH (1:1000, ab8245, Abcam) was used as the internal reference and relative expression was computed as the ratio of the grey value of the target band to that of the internal reference band.
| Statistical analysis
The SPSS 21.0 software (IBM Corp.) was employed for statistical analysis. All descriptive measurement data were summarized as mean ± SD. Comparisons between multiple groups were performed using one-way analysis of variance and comparisons between two groups were analysed using the t test, while pairwise comparisons were performed using the least-significant difference (LSD) test. P < .05 was statistically significant.
| RE SULTS
| VB promotes let-7g-5p expression in nude mice with xenograft tumours
A GBM-related microarray data set 'GSE103228' was obtained from the GEO database. Differentially expressed miRNAs in tumour samples versus those in normal samples were determined and it was found that miR-192, miR-96, and let-7g-5p were each differentially expressed in the GBM samples (Table 2) , consistent with other reports of these three miRNAs playing important roles in drug response of tumours. [19] [20] [21] [22] However, as it remained unclear whether these three miRNAs were affected by VB in GBM, the expression of miR-192, miR-96 and let-7g-5p in nude mice with xenograft GBM tumours was determined using RT-qPCR. As shown in Figure 1A ,B, miR-192, miR-96, and let-7g-5p were each highly expressed in nude mice with xenograft tumours. However, let-7g-5p was expressed at significantly higher levels in nude mice treated with VB (P < .05). These results indicated that VB was a promoter of let-7g-5p.
| VB has stronger inhibitory ability in cell viability of U87 and U251 cells than in A172, SHG139 and SHG-44 cells
The cell viability of A172, SHG139, SHG-44, U87 and U251 cells was determined after treatment with varying concentrations of VB using CCK-8. The results indicated that viability of A172, SHG139, SHG-44, U87 and U251 cells exhibited the same trend upon treatment with different concentrations of VB (0, 10, 20, 40, 60, 80 and 100 µmol/L) at 72 hours. The inhibitory rate was calculated based on the CCK-8 assay where cell viability was reflected by the OD value of each well at 570 nm (Figure 2A,B ). VB had an inhibitory effect on the viability of A172, SHG139, SHG-44, U87 and U251 cells.
When the concentration of VB was 0, cell viability and proliferation reached their respective maximum values. As the concentration of VB increased, cell viability and proliferation were decreased, with an elevated inhibitory rate. In comparison with A172, SHG139 and
TA B L E 1 Primer sequences for RT-qPCR
Genes
Forward sequences (5′-3′) Reserve primers (5′-3′)
Notes: All genes above were all obtained from NCBI.
Abbreviations: Bax, Bcl-2 associated X protein; Bcl-2, B-cell lymphoma-2; Caspase, cysteinyl aspartate specific proteinase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HMGA2, high mobility group A2; LC3, Autophagy marker Light Chain 3; let-7g-5p, microRNA let-7g-5p; NCBI, National Center for Biotechnology Information; PKC, protein kinase C; RT-qPCR, reverse transcription quantitative polymerase chain reaction; U6, U6 small nuclear. tion, the content of let-7g-5p in U87 and U251 cells was higher than that in A172, SHG139 and SHG-44 cells ( Figure 2C ).
TA B L E 2 Expression of miRNAs in GSE103228
| VB suppresses tumour growth of GBM in nude mice
U87 and U251 xenograft GBM tumours were induced in nude mice to study the effects of VB on the in vivo tumour growth. In comparison with the U87 group, tumour growth and volume during the first two weeks did not differ remarkably in the U87 + VB group 
| HMGA2 is confirmed as a target gene of let-7g-5p
Subsequently, let-7g-5p was examined in order to determine whether it could directly regulate HMGA2 using in silico target prediction and luciferase activity determination. The web-based bioinformatics prediction software indicated the presence of a target-binding site between HMGA2 and let-7g-5p, confirming HMGA2 as a target of let-7g-5p F I G U R E 1 VB promotes let-7g-5p expression in nude mice with xenograft tumours. A, the expression of miR-192, miR-96, let-7g-5p and U6 snRNA in nude mice injected with U87 cells; B, the expression of miR-192, miR-96, let-7g-5p and U6 snRNA in nude mice injected with U251 cells; * P < .05 vs U6 snRNA. All measurement data were summarized as mean ± SD. Comparisons among multiple groups were performed with one-way analysis of variance and comparisons between two groups were analysed using a t test. The experiment was repeated three times independently. VB, Verbascoside Figure 4A ). Luciferase activity determination further demonstrated that let-7g-5p directly targeted HMGA2. As shown in Figure 4B , cells treated with wt-let-7g-5p and HMGA2 plasmid showed significantly decreased luciferase activity when cotransfected with let-7g-5p mimic compared to co-transfection with NC mimic (P < .05). However, the luciferase activity of the cells treated with mut-let-7g-5p and HMGA2 plasmid did not differ significantly among groups (P > .05). These findings suggested that let-7g-5p could specifically bind to HMGA2.
The results of RNA pull-down assay ( Figure 4C ) revealed that HMGA2 mRNA was expressed at a higher level in the bio-let-7g-5p-wt group than in the bio-probe the NC group (P < .05). In addition, the HMGA2 mRNA expression did not differ significantly between the bio-probe NC group and the bio-let-7g-5p-mut group (P > .05). These results indicated that bio-let-7g-5p-wt could promote the enrichment of HMGA2 mRNA around it while bio-let-7g-5p-mut could not.
| VB and down-regulation of HMGA2 suppress GBM cells migration and invasion
In the following experiments, we mainly investigated the effects of VB on the migration and invasion of GBM cells by using a scratch The results of U251 cell experiments showed trends that were consistent with those observed in the U87 cells ( Figure S1A,B) .
The results of the transwell assay results using the U87 cells ( Figure 5C ,D) displayed a consistent trend. In comparison with the blank were similarly consistent with those of U87 cells (Figure S1C,D) .
These data suggested that VB application, up-regulation of let-7g-5p, as well as down-regulation of HMGA2 each served to inhibit the cell migration and invasion in GBM cells.
| VB promotes autophagy of U87 and U251 cells through the suppression of HMGA2 and the Wnt/βcatenin signalling pathway
To further elucidate the role of VB and HMGA2 in relation to protein expression and autophagy of U87 and U251 cell lines, the expression of let-7g-5p, Beclin1, β-catenin and HMGA2 in GBM cells was determined by laser confocal microscopy, RT-qPCR and Western blot analysis.
The laser confocal microscopy results revealed same trends for U87 and U251 cell lines ( Figures 6A,B, S2A RT-qPCR demonstrated that U87 and U251 cells shared the same trend ( Figures 6C, S2C) . The expression of let-7g-5p and Beclin1 was much higher, while HMGA2 and β-catenin were expressed at lower levels in the VB, VB-3-MA and let-7g-5p mimic groups in comparison with the blank and the NC groups (all P < .05). In comparison with the blank and the NC groups, the let-7g-5p inhibitor group exhibited significantly lower let-7g-5p and Beclin1 expression but higher HMGA2 and β-catenin expression (all P < .05), whereas these expression levels in the VB + let-7g-5p inhibitor group did not differ significantly (P > .05). The expression of let-7g-5p, Beclin1, HMGA2
and β-catenin showed no difference in the NC mimic group and the NC inhibitor group (all P > .05). In comparison with the NC mimic group, the HMGA2 vector group showed repressed expression of Beclin1, while that of HMGA2 and β-catenin was found elevated (all P < .05), with no differences in the expression of let-7g-5p (P > .05).
In the let-7g-5p mimic + HMGA2 vector group, let-7g-5p expression the NC inhibitor group, the si-HMGA2 group showed much higher LC3II/I and Beclin1 expression levels (P < .05) but these were significantly lower in the let-7g-5p inhibitor + si-HMGA2 group (P < .05).
These results suggested that let-7g-5p facilitated autophagy while overexpression of HMGA2 repressed autophagy. Flow cytometry results suggested parallel trends in U87 and U251 cells ( Figures 7E-F, S3E-F) . In comparison with the blank and NC groups, cell apoptosis was increased in the VB and let-7g-5p mimic groups, but decreased in the let-7g-5p inhibitor group (all P < .05). In addition, the VB + let-7g-5p inhibitor group did not differ significantly (P > .05). No significant difference was observed in cell apoptosis between the NC mimic and the inhibitor groups (P > .05). In the HMGA2 vector group, as compared with the NC mimic group, cell apoptosis was decreased (P < .05). No difference in the let-7g-5p mimic + HMGA2 vector group was noted (P > .05).
| VB promotes apoptosis of GBM cells
In the si-HMGA2 group, as compared to the NC inhibitor group, cell apoptosis was increased (P < .05), whereas the let-7g-5p inhibitor + si-HMGA2 group did not display any significant difference (P > .05). Overall, these results indicated that overexpression of let-7g-5p or knockdown of HMGA2 potentiated the apoptosis of GBM cells.
| VB impairs tumour growth in GBM through up-regulation of let-7g-5p
Next Relative expression of let-7g-5p
Relative expression of let-7g-5p Relative expression of let-7g-5p while let-7g-5p inhibitor + si-HMGA2 group showed significantly decreased expression (P < .05) ( Figure 8G-H) .
The findings displayed that VB-mediated let-7g-5p might inhibit the tumour growth of GBM in vivo via down-regulating HMGA2.
| VB blocks the PKC pathway through let-7g-5p
As previous findings have indicated, VB promotes carcinogenesis by inhibiting the PKC pathway. 23 whereas PKC expression in the let-7g-5p inhibitor + si-HMGA2 group was relatively higher than that in the si-HMGA2 group (Figure 9A,B) .
The results of U87 and U251 cell experiments were consistent ( Figure 9C,D) . These findings showed PKC could be blocked by VBmediated let-7g-5p overexpression in GBM cells.
| D ISCUSS I ON
GBM is a prototypical heterogeneous brain tumour that exhibits significant resistance to routine treatment and is frequently marked by a devastating rate of tumour recurrence. 24 Previous studies have shown that VB has protective effects against colorectal cancer and leukaemia, where it modulates the biological processes involved. 9, 25 Yet the effect of VB remains poorly understood. In the present study, the main objectives were to identify the let-7g-5p, HMGA2 axis, A key observation of this study is the ability of VB to enhance let-7g-5p expression and inhibit HMGA2 as well as Wnt/β-catenin signalling. Our experimental data initially demonstrated that VB could up-regulate let-7g-5p in GBM cell lines. VB is considered to have significant clinical value from a cancer perspective, owing to its neuroprotective and memory enhancement properties. 26 In agreement with our data, Areeb et al illustrated that let-7g-5p was significantly poorly expressed in patients with GBM. 27 The in silico target prediction and the luciferase activity assay demonstrated HMGA2 was a putative target gene of let-7g-5p, which was negatively governed by let-7g-5p. Studies have reported that the miR-let-7 family is associated with HMGA2, through which it co-regulates many cancers.
For instance, let-7 was found to act as a tumour suppressor by targeting HMGA2 in colorectal cancer, in a report by Madison et al. 28 Other experiments indicated that H19 promoted pancreatic ductal adenocarcinoma cell invasion and migration by activating let-7-mediated HMGA2. 29 In the present study, we demonstrated that HMGA2 activated the Wnt/β-catenin signalling pathway in GBM cells. Consistent with our findings, previous work in gastric cancer has shown that HMGA2 enhances epithelial-mesenchymal transitions via the activation of the Wnt/β-catenin signalling pathway. 30 Similarly, in hepatocellular carcinoma, the Wnt/β-catenin signalling pathway has been found to be activated by HMGA2, which results in inhibited tumour cell proliferation. 31 The most significant finding of our study is that VB treatment or up-regulation of let-7g-5p could repress GBM tumour cell viability, invasion and migration, while enhancing cell apoptosis and autophagy. In contrast, the overexpression of HMGA2 or activation of the Wnt/β-catenin signalling pathway led to the opposite results.
Consistent with our findings, VB was shown to suppress cell proliferation in gastric cancer. 32 Hugo et al demonstrated that VB was protective against prostate cancer, acting to reduce the levels of reactive oxygen species in cancer cells. 33 Zhou et al similarly found that VB up-regulated colorectal cancer cell apoptosis by activating the HIPK2-p53 signalling pathway. 25 Notably, our in vitro experiments indicated that VB could down-regulate PKC, a Wnt pathway-related gene, by modulating the expression of let-7g-5p. Its aberrant expression in GBM is noted to regulate cancer cell proliferation, apoptosis and invasiveness through downstream influence on multiple genes. 34 Zhang et al further elucidated that the up-regulation of let-7g-5p inhibits cell invasion and migration in GBM U-87MG cells, acting via a reduction in VSIG4. 10 HMGA2 is generally considered as a tumour promoter gene in several cancers. For instance, HMGA2 enhances lung carcinogenesis, serving as a protein-coding gene. 12 In a similar finding, Zhao et al noted HMGA2 overexpression in tongue cancer was associated with metastasis. 35 In GBM particularly, recent evidence has demonstrated that HMGA2 accelerates both tumour cell line stemness and cell invasion. 36 Abnormal Wnt/β-catenin signalling is shown to promote GBM carcinogenesis and progression. 37, 38 In accordance, the inhibition of Wnt/β-catenin signalling has been reported to negatively impact cell proliferation, migration and invasion in GBM. 17 Others have reported the activation of the Wnt/β-catenin signalling accelerates stemness of GBM cells. 39 To conclude, the current study provides evidence demonstrating that VB suppresses GBM cell viability, invasion and migration, while enhancing cell apoptosis and autophagy. These effects are achieved through the inhibition of let-7g-5p-mediated HMGA2 and blockade of the Wnt/β-catenin signalling pathway. These results suggest that VB may be a promising treatment modality for GBM. In addition, our findings also suggest that let-7g-5p, HMGA2 and the Wnt/β-catenin signalling pathway-related genes could have potential as predictive biomarkers for GBM. However, further experiments are needed to unravel the detailed mechanisms by which VB may cross the blood-brain barrier. In addition, investigations using orthotopic models are warranted in order to further validate the findings of the present study.
